Health 2.0 – How Empowering Patients can Lead to Increased Patient Acquisition
Wendy White, President, Siren Interactive – Social networking and how to use it to reach patients. Presentation from the Centric Health Resources Ultra-Orphan Conference 2009. (Length 39:02)
|
The New Administration and the Impact on Orphan Drug Development
Jayson Slotnick, M.P.H., Esq., Hogan & Hartson – A health reform status update. Presentation from the Centric Health Resources Ultra-Orphan Conference 2009. (Length 29:25)
|
Including Distribution and Patient Services in Ultra-Orphan Pricing
Doug Paul, PharmD, MS, Medical Marketing Economics, LLC – The intersection of the forgotten P’s of the marketing mix.” What is the Missing P? Patients! Presentation from the Centric Health Resources Ultra-Orphan Conference 2009. (Length 38:04)
|
Why Smaller Is Better – The Triumph of the Biotech Model
Michael McCaughan, Editor- in-Chief, FDC-Windhover Biopharma Group – An eye-opening overview of the new FDA, with its tougher enforcement tools and how the new regulatory model favors the smaller, more nimble “biotech” organization. Presentation from the Centric Health Resources Ultra-Orphan Conference 2009. (Length 45:25)
|
Reimbursement and Benefit Trends
Dennis Matheis, President, Anthem Blue Cross and Blue Shield in Missouri – An overview of current reimbursement trends. Presentation from the Centric Health Resources Ultra-Orphan Conference 2009. (Length 39:45)
|
Integrate Risk Evaluation & Mitigation Strategies (REMS) with Health Management & Distribution
Craig Kephart, President & CEO, Centric Health Resources – The benefits of integrating REMS requirements with distribution. Presentation from the Centric Health Resources Ultra-Orphan Conference 2009. (Length 56:18)
|
Regulatory/REMS/Health Intelligence
David A. Galardi, Pharm. D., Commercial Operations, Apogenics – The “nuts and bolts” of REMS, including history, resources, definitions, and techniques for meeting REMS obligations and maintaining commerce. Presentation from the Centric Health Resources Ultra-Orphan Conference 2009. (Length 42:03)
|
The New Administration & The Impact on Orphan Drug Development: The Good, Bad and Ugly
Diane Edquist Dorman, Vice President, Public Policy, NORD – NORD’s advocating efforts for FOB legislation. Presentation from the Centric Health Resources Ultra-Orphan Conference 2009. (Length 13:34)
|
Centric Featured on American Health Journal TV
Craig Kepardt, Centric CEO, describes Centric's unique business model and how Centric serves the ultra-orphan drug market with patient centered health management. (Length 4:11)
|
Dennis Matheis - 2008 Centric Conference
Hear about reimbursement trends and what these trends mean for high-cost specialty drugs. (Length 5:04)
|
John Walsh - 2008 Centric Conference
John Walsh, President, CEO & Co-Founder, The Alpha-1 Foundation, discusses the benefits of involving the patient community early on in the development process. (Length 4:16)
|
Craig Kephart - 2008 Centric Conference
Craig Kephart, Centric CEO, reviews specialty pipeline trends and sources of margin pressure in the marketplace. (Length 2:58)
|